We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 132

Antitrust and competition - the EU weekly briefing (14 March 2016)
  • Winston & Strawn LLP
  • Denmark, European Union, France, Greece, United Kingdom
  • March 14 2016

Commission approves McKesson acquisition of UDG Healthcare in the EEA but refers UK element to the CMA for approval. On 4 March 2016


Alerta Productos de Consumo - Agosto 2016
  • CMS Albiñana & Suárez de Lezo
  • Austria, European Union, France, Germany, Greece, Portugal, Romania, Slovakia, Spain, United Kingdom
  • August 3 2016

En los últimos tiempos se han publicado varias noticias sobre investigaciones de sistemas de franquicia por parte de las autoridades de competencia


Syfait II
  • NautaDutilh
  • European Union, Greece
  • September 17 2008

Yesterday, the EC Court of Justice (ECJ) handed down its long awaited judgment in the Syfait II Case (Joined Cases C-46806 - C-47806, Sot. Lélos kai Sia), which deals with stock management in the pharmaceutical sector


ECJ delivers long-awaited judgment in Glaxo ‘Greek’ Case on parallel imports
  • Hogan Lovells
  • European Union, Greece
  • September 22 2008

On September 16, 2008, the European Court of Justice (ECJ) handed down a long-awaited judgment in Sot Lélos kai Sia EE and Others v. GlaxoSmithKline AEVE Farmakeftikon Proïonton1 (the Greek Glaxo Case


Parallel trade in medicines: ECJ judgment in the second reference re: GlaxoSmithKline’s supply policy in Greece and abuse of dominant position
  • Bird & Bird
  • European Union, Greece
  • October 16 2008

In the second reference to the European Court of Justice arising out of GSK’s policy of selling medicines directly to Greek hospitals and pharmacies the ECJ has held (Joined Cases C-46806 to C-47806 Sot. Lelos kai Sia and Others) that an undertaking which occupies a dominant position on the relevant market for medicinal products is abusing its dominant position contrary to Article 82 EC if, in order to stop parallel exports, it refuses to meet “ordinary orders” from wholesalers


The General Court of the EU overturns the two European Commission lignite decisions
  • Hogan Lovells
  • European Union, Greece
  • October 31 2012

In two landmark rulings on 20 September 2012, the General Court of the European Union in Luxembourg annulled the two European Commission decisions on the Greek “lignite” case


AG gives Opinion in pharmaceutical parallel trade case
  • Nabarro LLP
  • European Union, Greece
  • April 16 2008

On 1 April 2008, Advocate-General Colomer (AG) gave his Opinion, on a reference from a Greek court, on whether a refusal by a dominant pharmaceutical company to meet the full orders of wholesalers amounted to an abuse of a dominant position contrary to Article 82 of the EC Treaty


Advocate General’s opinion supporting parallel trade in Greek case against GSK
  • Bird & Bird
  • European Union, Greece
  • May 7 2008

The long running saga of disputes between Greek exporter wholesalers and GSK following GSK’s refusal of supplies for export purposes has taken a new turn


European Court provides preliminary ruling on the legality of OPAP's monopoly
  • Olswang LLP
  • European Union, Greece
  • January 25 2013

On 24 January 2013, the Court of Justice of the European Union handed down a preliminary judgment on questions referred to it by the Greek courts in


Refusal to meet ordinary orders may amount to an abuse
  • Nabarro LLP
  • European Union, Greece
  • September 25 2008

On 16 September 2008, the European Court of Justice gave a ruling (in joined cases C-46806 C-47806) on questions referred by a Greek court, concerning whether the failure of a company to meet the orders of a wholesaler may amount to an abuse of a dominant position